Conclusion
Taken together, these results show the usefulness of the perifusion technique both in the studyof hormone regulation and in the physiopathology of the human pituitary. It allows the studyof dynamic changes in hormone release, relationships between in vivo and in vitro responses, relationships between hormone response and receptor status. Furthermore, we could use this approach to demonstrate release of pituitary neuropeptides and the relation between secretoryprofiles of neuropeptides and those of pituitary hormones. It is another approach to all thesedifferent points than long term culture that needs enzymatic dispersion, and several days ofrecovery before any experiment can be performed on the cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
BRESSION, D., BRANDI, A.M., MARTRES, M.P., NOUSBAUM, A., CESSELIN, F., RACADOT, J., and PEILLON, F. (1980). Dopaminergic receptors in human prolactin-secreting adenomas: a quantitative study. J. Clin. Endocrinol. Metab. 51:1037–1043.
BRESSION, D., BRANDI, A.M., NOUSBAUM, A., auLE DAFNIET, M., RACADOT, J., and PEILLON, F. (1982). Evidence of dopamine receptors in human growth hormone (GH)-secreting adenomas with concomittant study of dopamine inhibition of GH secretion in a perifusion system. J. Clin. Endocrinol. Metab. 55:589–593.
GERSHENGORN, M.C. and PAUL, M.E. (1986). Evidence for tight coupling of receptor occupancy by thyrotropin releasing hormone to phospholipase C-mediated phospholnositide hydrolysis in rat pituitary cells: use of chlordiazepoxide as a competitive antagonist. Endocrinology. 119:833–839.
JOUBERT-BRESSION, D., BENLOT, C., LAGOGUEY, A., GARNIER, P., BRANDI, A.M., GAUTRON, J.P., LEGRAND, J.C., and PEILLON, F. (1989). Normal and growth hormone (GH)-secreting adenomatous human pituitaries release somatostatin an GH-releasing hormone. J. Clin. Endocrinol. Metab. 68:572–577.
LE DAFNIET, M., BRANDI, A., BRESSION, D., RACADOT, J., and PEILLON, F. (1983). Evidence of receptors for thyrotropin-releasing hormone (TRH) in human prolactin-secreting adenomas. J. Clin. Endocrinol. Metab. 57:425–427.
LE DAFNIET, M., LEFEBRE, P., BARRET, A., MECHAIN, C., FEINSTEIN, M.C., BRANDI, A.M., and PEILLON, F. (1990). Normal and adenomatous human pituitaries secrete thyrotropin-releasing hormone in vitro: modulation by dopamine, haloperidol and somatostatin. J. Clin. Endocrinol. Metab. 71:480–486.
PEILLON, F., LE DAFNIET, M., GARNIER, PH., BRANDI, A.M., MOYSE, E., BIRMAN, P., BLUMBERG-TICK, J., GROUSELLE, D., and JOUBERT-BRESSION, D. 1989. Receptors and neuroghormones studies in human pituitary adenomas. Hormone Res. 31:13–18.
SCHETTINI, G., CRONIN, M.J., HEWLETT, E.L., THORNER, M.O., and MAC LEOD, R.M. (1984). Human pancreatic tumor growth hormone-releasing factor stimulate anterior pituitary adenylate cyclase activity, adenosine 3′,5′-monophosphate accumulation and growth hormone release in a calinodulin-dependent manner. Endocrinology. 115: 1308–1314.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Joubert, D., Brandi, A. & Peillon, F. Perifusion system: its use in the study of the neuroendocrine control of human pituitary tumoral cells. Cell Biol Toxicol 8, 39–47 (1992). https://doi.org/10.1007/BF00130509
Issue Date:
DOI: https://doi.org/10.1007/BF00130509